Organization
Princeton Health
10 abstracts
Abstract
A longitudinal, palliative care educational pilot in hematology-oncology fellowship training.Org: Princeton Health,
Abstract
Health-related quality of life (HRQOL) in patients (pts) with advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC) or esophageal adenocarcinoma (EAC): 36-month results of nivolumab plus chemotherapy (N+C) versus (C) from CheckMate 649.Org: Princess Margaret Cancer Centre, University Health Network, Klinika Onkologii i Radioterapii, Narodowy Instytut Onkologii, Bristol Myers Squibb,
Abstract
Baseline characteristics identifying patients (pts) with multiple myeloma (MM) treated with idecabtagene vicleucel (ide-cel; bb2121) who are at risk for severe/refractory inflammatory adverse events (iAEs).Org: Bristol Myers Squibb, Princeton Health, Lille University Hospital, Lille, France, Mayo Clinic,
Abstract
Machine learning prediction of progression events in oncology RECIST 1.1 clinical trials.Org: Clario, Princeton Health,
Abstract
ABATACEPT IS EFFECTIVE AT REDUCING PAIN AND FATIGUE, AND IMPROVING SLEEP QUALITY IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO ANTI-TNF THERAPY IN THE ATTAIN TRIALOrg: University of Alberta Hospital, Edmonton, Canada, Centre for Rheumatology, University College London Hospital, London, United Kingdom, Immunology and Arthritis, Fort Lauderdale, United States,
Abstract
Absence of association between drug exposure and infection in patients with polyarticular-course juvenile idiopathic arthritis and inadequate response to biologic or non-biologic dmards treated with sc and iv abataceptOrg: PRINTO-Istituto Gaslini, Genova, Italy, Istituto Gaslini, Genoa, Italy, PRCSG-Children's Hospital Cincinnati, Ohio, United States,
Abstract
A PHASE IIB, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND CLINICAL EFFICACY OF TWO DIFFERENT DOSES OF CTLA4IG ADMINISTERED INTRAVENOUSLY TO SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITISOrg: Primus Pharmaceuticals, Bristol-Myers Squibb, Princeton Health, Rheumatology, Center of Rheumatology,
Abstract
A COMPARISION OF THE MEDICAL OUTCOMES STUDY (MOS) SLEEP SCALES WITH A VISUAL ANALOGUE SLEEP DISTURBANCE SCALE IN PATIENTS WITH RHEUMATOID ARTHRITISOrg: Outcomes Research Consortium, National Data Bank for Rheumatic Diseases, Center for Primary Care and Outcomes Research, Stanford University School of Medicine, Wichita,
Abstract
ABATACEPT PROVIDES SIGNIFICANT AND CLINICALLY MEANINGFUL EFFICACY IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSES TO ANTI-TNF THERAPY: DISEASE ACTIVITY SCORE 28 ASSESSMENTS IN THE ATTAIN TRIALOrg: Rene Descartes University, Service de Rhumatologie B, Hôpital El Ayachi, Salé, Morocco, Service de Rhumatologie et de Pathologie Osseuse, Pavillon F, Hôpital. E - Herriot, Lyon, France, Paris Cité University, France, Centre for Rheumatology, University College London Hospital, London, United Kingdom,
Abstract
ABATACEPT DISPLAYS LOW LEVELS OF IMMUNOGENICITY IN THE TREATMENT OF RHEUMATOID ARTHRITISOrg: Immunotoxicology, Drug Safety Evaluation, Bristol-Myers Squibb, Syracuse, NY, Clinical Discovery,